PFE

Pfizer Inc

Feb 02 • 04:00PM ET

26.66

+0.22 0.83 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Today, 6:50 AMPfizer reports Q4 EPS $0.66 and FY2025 EPS $3.22 on $62.6B revenue, reaffirms 2026 guidance for $59.5-$62.5B revenue and $2.80-$3.00 EPS, and posts positive Phase 2b VESPER-3 topline for ultra-long-acting GLP-1 obesity drug PF'3944 supporting monthly dosing, with Phase 3 planned in 2026.

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN-D

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Scroll to Statements

Index	S&P 500	P/E	15.54	EPS (ttm)	1.72	Insider Own	0.09%	Shs Outstand	5.69B	Perf Week	3.01%
Market Cap	151.58B	Forward P/E	8.96	EPS next Y	2.97	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	7.07%
Enterprise Value	198.60B	PEG	-	EPS next Q	0.57	Inst Own	66.75%	Short Float	2.29%	Perf Quarter	9.76%
Income	9.80B	P/S	2.41	EPS this Y	0.31%	Inst Trans	-0.36%	Short Ratio	2.10	Perf Half Y	13.50%
Sales	62.78B	P/B	1.63	EPS next Y	-4.64%	ROA	4.58%	Short Interest	129.80M	Perf YTD	7.07%
Book/sh	16.32	P/C	10.12	EPS next 5Y	-2.89%	ROE	10.59%	52W High	27.69 -3.72%	Perf Year	-0.93%
Cash/sh	2.64	P/FCF	14.61	EPS past 3/5Y	-28.69% -13.27%	ROIC	6.52%	52W Low	20.92 27.47%	Perf 3Y	-39.75%
Dividend Est.	1.71 (6.41%)	EV/EBITDA	7.59	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	69.12%	Volatility	2.17% 2.01%	Perf 5Y	-28.54%
Dividend TTM	1.72 (6.45%)	EV/Sales	3.16	EPS Y/Y TTM	128.96%	Oper. Margin	30.99%	ATR (14)	0.52	Perf 10Y	-7.77%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.97	Sales Y/Y TTM	4.44%	Profit Margin	15.60%	RSI (14)	62.15	Recom	2.39
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.28	EPS Q/Q	-20.96%	SMA20	3.58%	Beta	0.44	Target Price	28.69
Payout	120.11%	Debt/Eq	0.66	Sales Q/Q	-5.92%	SMA50	4.53%	Rel Volume	0.80	Prev Close	26.44
Employees	81000	LT Debt/Eq	0.62	Earnings	Feb 03 BMO	SMA200	8.20%	Avg Volume	61.95M	Price	26.66
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	37.53% 0.94%	Trades		Volume	52,129,516	Change	0.83%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51

Show Previous Ratings

Today 08:19AM	Merck and Pfizer decline vs the broader market as results released (Quartz)
07:38AM	Pfizer Reaffirms FY26 Outlook As Q4 Results Top Estimates - Update (RTT News)
07:32AM	Stocks to Watch Tuesday: PayPal, PepsiCo, AMD (The Wall Street Journal)
07:28AM	Pfizer says once-a-month weight-loss drug works as it forecasts profit decline (MarketWatch)
07:24AM	Jim Cramer Expresses Concern About Pfizer Despite Its "Terrific Yield" (Insider Monkey)
07:21AM	Loading…
07:21AM	Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand (The Wall Street Journal)
07:19AM	Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4 CY2025 (StockStory)
07:02AM	Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. (Barrons.com)
06:53AM	Pfizer: Q4 Earnings Snapshot (Associated Press Finance)
06:45AM	Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance (Business Wire)
06:40AM	Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial (Business Wire)
06:09AM	These Stocks Are Todays Movers: Palantir, Teradyne, Tesla, PepsiCo, AMD, NXP Semiconductors, and More (Barrons.com)
05:25AM	These Stocks Are Moving the Most Today: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, and More (Barrons.com)
05:12AM	Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure (Insider Monkey)
05:00AM	Advanced Micro Devices heads earnings slate (MarketWatch)
04:19AM	Loading…
04:19AM	Stock Market Today: S&P 500 eyes fresh record as Dow and Nasdaq also called higher; Palantir rises after earnings; gold and silver rebound; AMD results on tap. (MarketWatch)
03:01AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-02-26 07:00PM	AMD earnings, Netflix-Warner Bros. hearing: What to Watch (Yahoo Finance Video)
06:02PM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
02:08PM	Is Novo Nordisk Stock a Bargain Right Now? (Motley Fool)
01:59PM	Sanofi Found In Breach Of UK Pharmaceutical Marketing Code Over Beyfortus Claims (Benzinga)
11:12AM	Market Awaits January Manufacturing Numbers (Zacks)
10:35AM	Six More Weeks of Q4 Earnings Season? (Zacks)
10:25AM	What's in Store for These 5 Pharma Bigwigs This Earnings Season? (Zacks)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
08:10AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings? (Zacks)
07:00AM	Option Volatility And Earnings Report For February 2 - 6 (Barchart)
06:52AM	3 Headwinds Facing Pfizer in 2026 (Motley Fool)
06:31AM	How Pfizers CEO wielded moral clarity to help his team do the impossible (Fortune)
06:07AM	Analysis-Obesity market sales potential tightens as Novo and Lilly enter new era (Reuters)
02:13AM	Loading…
02:13AM	Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-01-26 10:03PM	Earnings To Watch: Pfizer (PFE) Reports Q4 Results Tomorrow (StockStory)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
06:20AM	Here's Why Pfizer Stock Is Still a Buy (Motley Fool)
Jan-31-26 08:28PM	Passive Income Investors Will Love These Cheap Dividend Stocks (24/7 Wall St.)
07:49AM	Cantor Fitzgerald Raises Pfizer (PFE) PT to $27 Amid Shifting Obesity Data Focus (Insider Monkey)
Jan-30-26 04:57PM	Jobs Report, More Tech Earnings: What to Watch Next Week (The Wall Street Journal)
01:22PM	Well save the world from cancer: Inside Pfizer CEOs $23 billion postCOVID bet on oncology (Fortune)
11:28AM	Regeneron Pharmaceuticals Q4 Earnings Call Highlights (MarketBeat)
10:19AM	$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors (PR Newswire)
09:23AM	AstraZeneca Strikes Multibillion-Dollar Obesity Deal With Chinas CSPC Pharmaceuticals (The Wall Street Journal)
09:00AM	Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know (Zacks)
08:49AM	Will BMY's Oncology Collaborations Drive Its Next Growth Phase? (Zacks)
08:39AM	CRMD Down 31% in a Month: Is This an Indication to Sell the Stock? (Zacks)
07:58AM	Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings? (Zacks)
07:50AM	Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings (Zacks)
07:20AM	3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year (Motley Fool)
05:31AM	AstraZeneca Strikes Obesity Multibillion-Dollar Deal With Chinas CSPC Pharmaceuticals (The Wall Street Journal)
Jan-29-26 07:26PM	Pfizer CEO says he used emotional blackmail to get employees to achieve impossible goals during COVID-19 (Fortune)
01:00PM	The Week Ahead: Big-Name Earnings, Jobs Data on Tap (Schaeffer's Research)
09:15AM	Ahead of Pfizer (PFE) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
07:23AM	3 High-Yield Stocks to Buy Hand Over Fist in January (Motley Fool)
02:07AM	Pfizer Inks $530M Deal for Novavax Matrix-M Adjuvant Technology to Boost Vaccine Pipeline (Insider Monkey)
Jan-28-26 07:23PM	This Could Be 1 of the Best Pharmaceutical Stock-Buying Opportunities I've Seen in Years (Motley Fool)
10:49AM	The beginning of the end: Eliquis sales forecast to plummet as EU patent expiry nears (Pharmaceutical Technology)
09:48AM	Some of Pharma's Biggest Brands Face a New Reality (GuruFocus.com)
07:48AM	CMS selects next batch of 15 high-cost medicines for third negotiation cycle (Pharmaceutical Technology)
05:51AM	Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle (Benzinga)
05:26AM	Amazon, JPMorgan Lead Return-To-Office Push While Turning To Coworking Spaces Amid Workforce Uncertainty (Benzinga)
03:00AM	Has Novavax cracked the code for survival in the vaccine arena? (Pharma Voice)
Jan-27-26 05:45PM	Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider (Zacks)
01:12PM	Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's Drug (Benzinga)
10:45AM	Pfizer, Merck, CoreWeave, Zoom: Top Analyst Calls (Yahoo Finance Video)
10:00AM	Earnings Preview: Pfizer (PFE) Q4 Earnings Expected to Decline (Zacks)
09:27AM	Where Will Eli Lilly Be in 10 Years? (Motley Fool)
05:38AM	Pfizers CEO on leading after a moonshotand making deals with Trump (Fortune)
05:32AM	What Are Wall Street Analysts' Target Price for Pfizer Stock? (Barchart)
04:10AM	Roche Obesity Shot Helps Patients Lose Weight in Midstage Trial (The Wall Street Journal)
Jan-26-26 12:16PM	Novavax Stock Is Surging Monday: What's Driving The Action? (Benzinga)
10:06AM	Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag (Benzinga)
Jan-25-26 02:38PM	Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership (Insider Monkey)
05:30AM	Can Trump and Big Pharma Get the World to Pay More for Drugs? (The Wall Street Journal)
Jan-24-26 01:35PM	The Best Stocks to Invest $40 in to Start the New Year Off Right (Motley Fool)
Jan-23-26 12:36PM	Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research (Benzinga)
10:59AM	Will CRMD'S Bearish 2026 View Impact DefenCath's Long-Term Adoption? (Zacks)
10:20AM	The Top Stock to Buy With $30 for 2026 (Motley Fool)
08:36AM	Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q4 Earnings (Zacks)
Jan-22-26 09:21PM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
04:59PM	Clorox to Buy Purell-Maker Gojo for $2.25 Billion (The Wall Street Journal)
04:53PM	LIVE: CNBC anchor Andrew Ross Sorkin moderates a panel on global economic outlook in Davos 1/23/26 (CNBC TV)
12:51PM	FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer (Benzinga)
09:15AM	Is BMY's Deep Pipeline the Key to Its Next Growth Phase? (Zacks)
06:50AM	Is Pfizer an Absurdly Cheap Dividend Stock, or Just a Value Trap? (Motley Fool)
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
12:01AM	Johnson & Johnson Crushes Patent, Pricing Probs (The Daily Upside)
Jan-21-26 05:45PM	Pfizer (PFE) Outperforms Broader Market: What You Need to Know (Zacks)
10:06AM	Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer (Zacks)
09:39AM	Albert Bourla on the State of Pharma (WSJ)
08:26AM	Pfizer CEO on His Relationship With RFK Jr. (WSJ)
07:25AM	Pfizer and Novavax ink $530m vaccine delivery licensing deal (Pharmaceutical Technology)
06:46AM	3 No-Brainer Dividend Stocks to Buy Right Now -- Including Pfizer (Motley Fool)
04:06AM	Trump at Davos, Intel Earnings, Supreme Court: What to Watch This Week (The Wall Street Journal)
Jan-20-26 04:57PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:43PM	Pfizer CEO Albert Bourla: U.S. drug prices are coming down (CNBC TV)
03:58PM	Valneva Steps Back From US Approval Bid For Chikungunya Vaccine (Benzinga)
01:41PM	BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? (Zacks)
12:53PM	Novavax Pops on Pfizer Licensing Deal (GuruFocus.com)
12:14PM	Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up (Pharmaceutical Technology)
10:42AM	Novavax Shares Rise After Licensing Deal With Pfizer (Benzinga)
10:41AM	Novavax Licenses Rights to Key Vaccine Component to Pfizer (The Wall Street Journal)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience